Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,212
Closed -$778K 116
2026
Q1
$778K Sell
2,212
-2,501
-53% -$892K 0.22% 111
2025
Q4
$1.54M Sell
4,713
-625
-12% -$198K 0.48% 63
2025
Q3
$1.51M Buy
5,338
+290
+6% +$84.1K 0.46% 78
2025
Q2
$1.41M Buy
5,048
+392
+8% +$111K 0.4% 98
2025
Q1
$1.45M Sell
4,656
-992
-18% -$293K 0.46% 91
2024
Q4
$1.47M Sell
5,648
-5,341
-49% -$1.58M 0.49% 86
2024
Q3
$3.54M Buy
+10,989
New +$3.59M 1.01% 16
2024
Q1
Sell
-2,118
Closed -$610K 221
2023
Q4
$610K Sell
2,118
-228
-10% -$62.1K 0.19% 138
2023
Q3
$631K Buy
+2,346
New +$585K 0.22% 143
2023
Q2
Sell
-1,745
Closed -$422K 237
2023
Q1
$422K Buy
1,745
+88
+5% +$21.6K 0.15% 161
2022
Q4
$435K Sell
1,657
-528
-24% -$142K 0.15% 169
2022
Q3
$492K Sell
2,185
-3,755
-63% -$910K 0.18% 101
2022
Q2
$1.45M Sell
5,940
-2,061
-26% -$505K 0.38% 43
2022
Q1
$1.94M Buy
8,001
+1,863
+30% +$428K 0.42% 46
2021
Q4
$1.38M Sell
6,138
-464
-7% -$97.9K 0.23% 87
2021
Q3
$1.4M Buy
6,602
+419
+7% +$96.4K 0.27% 87
2021
Q2
$1.51M Buy
6,183
+134
+2% +$33K 0.28% 89
2021
Q1
$1.5M Sell
6,049
-5,050
-45% -$1.2M 0.29% 84
2020
Q4
$2.55M Buy
11,099
+6,208
+127% +$1.43M 0.49% 33
2020
Q3
$1.24M Buy
+4,891
New +$1.21M 0.34% 74
2020
Q2
Sell
-3,783
Closed -$767K 63
2020
Q1
$767K Sell
3,783
-10,070
-73% -$2.2M 0.17% 20
2019
Q4
$3.34M Sell
13,853
-8,588
-38% -$1.89M 0.52% 45
2019
Q3
$4.34M Sell
22,441
-13,955
-38% -$2.68M 0.62% 42
2019
Q2
$6.71M Buy
+36,396
New +$6.52M 0.78% 35

Other funds holding AMGN

Donoghue Forlines's AMGN Position: Q2 2026 in Review

Donoghue Forlines sold out of Amgen (AMGN) in Q2 2026, closing a stake of 2,212 shares — an estimated $778K sold.

Donoghue Forlines first reported a position in AMGN in Q2 2019 and held it in 24 quarters. The position peaked at $6.71M in Q2 2019. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Donoghue Forlines reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Donoghue Forlines sold 2,212 Amgen shares in Q2 2026, an estimated $778K.
  • Donoghue Forlines first reported a position in Amgen in Q2 2019 and held it in 24 quarters.
  • Donoghue Forlines's Amgen position peaked at $6.71M in Q2 2019.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.